another new "glitazone" for type 2 diabetes, Actos (pioglitazone)
August 1999
You'll soon see another new "glitazone" for type 2 diabetes, Actos (pioglitazone)...co-marketed by Lilly and Takeda.
This is the third one...after Avandia (rosiglitazone) and Rezulin (troglitazone).
All three lower blood glucose by improving insulin sensitivity.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote